Opioid Addiction

Featured Article

An Overview of Using Naloxone and Opioids for Pain Management

An Overview of Using Naloxone and Opioids for Pain Management

The increased use of opioid prescriptions to treat chronic pain has resulted in the rise of opioid use disorder, addiction, and abuse. We offer an overview of how and when to prescribe opioids for the management of chronic pain.

Latest

Opioid Prescriptions Following Common Surgeries: Optimal Durations

Opioid Prescriptions Following Common Surgeries: Optimal Durations

Optimal opioid prescription durations following surgical procedures were shown to vary from 4 to 15 days, depending on the type of surgical procedure.

Emergency Department Opioid Prescriptions Align With CDC Guideline

Emergency Department Opioid Prescriptions Align With CDC Guideline

Opioids prescriptions to opioid-naive patients in the ED setting were shown to be more in line with the CDC recommendations and less likely to lead to long-term opioid use compared with non-ED prescriptions.

FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids

FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids

The FDA has recently issued a report advising against the use of buprenorphine and methadone medications in patients taking benzodiazepines and/or other central nervous system depressants.

Low Potential for Abuse With Extended-Release Oxycodone

Low Potential for Abuse With Extended-Release Oxycodone

An abuse liability assessment was conducted to determine the abuse potential and pharmacokinetics of extended-release vs immediate-release oxycodone.

Stigma Among Individuals Seeking Treatment for Opioid Abuse

Stigma Among Individuals Seeking Treatment for Opioid Abuse

Self-stigma and perceived stigma were shown to be highest among people with opioid use disorders who have previously entered detoxification programs or who have recently injected drugs.

CVS to Limit Opioids Dispensed to Opioid-Naive Patients to a 7-day Supply

CVS to Limit Opioids Dispensed to Opioid-Naive Patients to a 7-day Supply

At the pharmacy level, a greater emphasis will be placed on counseling to help patients understand the risks associated with opioid use based on the new Centers for Disease Control and Prevention (CDC) guidelines.

Naloxone Co-Prescribing to Fight Opioid Overdoses: An AMA Recommendation

Naloxone Co-Prescribing to Fight Opioid Overdoses: An AMA Recommendation

Co-prescribing naloxone with opioids may reduce opioid overdoses while playing a pivotal role in combating the nation's opioid addiction epidemic.

Long-Term Pharmacotherapy Strategies for Substance Use Disorder Management

Long-Term Pharmacotherapy Strategies for Substance Use Disorder Management

New pharmacotherapies in combination with psychotherapy and counseling have proven effective in preventing relapse.

FDA Approves Marketing of Substance Abuse Treatment App

FDA Approves Marketing of Substance Abuse Treatment App

The FDA has permitted marketing of the first mobile app to help treat substance abuse use disorders, including alcohol, cocaine, marijuana, or other stimulants.

Abuse-Deterrent Opioids Might Not Be the Answer to the Opioid Crisis

Abuse-Deterrent Opioids Might Not Be the Answer to the Opioid Crisis

Abuse-deterrent opioid formulations may not be the most effective solution to the opioid crisis, according to an editorial published in the New England Journal of Medicine.

Collaborative Care Superior to Standard Care for Opioid Use Disorder

Collaborative Care Superior to Standard Care for Opioid Use Disorder

Patients with opioid and/or alcohol use disorders have better treatment access and greater rates of alcohol and drug abstinence at 6 months with collaborative care vs standard addiction care.

Long-Term Opioid Rx Use Skyrocketed Between 1999 and 2014

Long-Term Opioid Rx Use Skyrocketed Between 1999 and 2014

Long-term opioid prescription use increased threefold during a 16-year period between 1999 and 2014.

Balanced Pain Management and Overdose Prevention Strategies

Balanced Pain Management and Overdose Prevention Strategies

At PAINWeek 2017, the president of the National Association of Drug Diversion Investigators discussed ways to balance pain management needs and overdose prevention measures.

Virtual Reality for Pain Management: A Weapon Against the Opioid Epidemic?

Virtual Reality for Pain Management: A Weapon Against the Opioid Epidemic?

Virtual reality is on the verge of revolutionizing pain management, including on the chronic pain front, and may offer a new way to combat the opioid crisis.

Opioid Epidemic Declared National Emergency by White House

Opioid Epidemic Declared National Emergency by White House

The opioid epidemic has been declared a national emergency by President Donald Trump, which means federal funding can be increased and directed toward treatment programs.

Migraine Treatment: Are Opioids Overprescribed?

Migraine Treatment: Are Opioids Overprescribed?

There are nearly as many migraine patients receiving opioids as there are patients receiving level A abortive medications.

Long-Term Opioid Therapy Linked to Adverse Effects in Polyneuropathy

Long-Term Opioid Therapy Linked to Adverse Effects in Polyneuropathy

Long-term treatment with opioids is associated with more adverse outcomes in patients with polyneuropathy, including depression, overdose, and opioid dependence.

Comprehensive Initiative Positively Impacts Opioid Prescribing

Comprehensive Initiative Positively Impacts Opioid Prescribing

After a comprehensive initiative to curb opioid prescribing, researchers identified reductions in all tracked outcomes, including a 30% decrease in prescribing opioids at high doses.

Neonatal Withdrawal Risk Higher With Opioids Plus Psychotropic Drugs

Neonatal Withdrawal Risk Higher With Opioids Plus Psychotropic Drugs

The infants of women taking opioids concomitantly with psychotropic medications were found to have a substantially heightened risk of neonatal drug withdrawal.

Tramadol Effective on Opioid Withdrawal Symptoms

Tramadol Effective on Opioid Withdrawal Symptoms

The extended-release formulation of tramadol was shown to be as effective as buprenorphine and more effective than clonidine for treating symptoms of opioid withdrawal.